On the other hand, PRL signaling targets the Bcl-6 protein and increases the expression of the transcription inhibitor ZEB1 to suppress the expression of E-cadherin and promote the EMT of breast cancer cells [58]. Here, CDH1 is linked to breast carcinoma.